tiprankstipranks
Trending News
More News >
Wandisco Plc (GB:CRTA)
LSE:CRTA

Wandisco (CRTA) AI Stock Analysis

Compare
14 Followers

Top Page

GB:CRTA

Wandisco

(LSE:CRTA)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - 5.2)
Rating:54Neutral
Price Target:
22.50p
▲(7.14% Upside)
Cirata's overall stock score is primarily impacted by its financial challenges, including negative cash flows and profitability issues. However, recent strategic moves and positive corporate events provide some optimism for future growth. Technical indicators and valuation metrics remain weak, tempering the overall outlook.
Positive Factors
Revenue and bookings acceleration
Sustained H1 revenue growth (+40% YoY) and a 58% rise in bookings indicate expanding product adoption and stronger sales momentum in core markets. For a subscription-driven software business, higher bookings improve future recurring revenue visibility and support scaling of margins over the medium term.
Strategic refocus on data integration
Divesting non-core DevOps assets and monetizing them for cash lets management reallocate capital and operational focus to the higher-growth data integration segment. Concentrating R&D and sales on a core product line can improve unit economics and long-term margin sustainability if execution continues.
Enterprise deals and cloud partnerships
Securing enterprise-wide licenses and a Microsoft Azure partnership strengthens market credibility and distribution reach, increasing customer stickiness for recurring subscriptions. These structural partnerships help lower acquisition costs and accelerate enterprise adoption over multiple quarters.
Negative Factors
Persistent negative free cash flow
Multi-year negative free cash flow and poor operating-cash-to-income conversion indicate the business is not self-funding growth. Continued dependency on financing risks dilution or constrained investment capacity, limiting the firm's ability to sustainably fund sales, R&D, and go-to-market expansion.
Deep negative profitability and margins
Despite solid gross margins, persistent operating losses and deeply negative EBITDA imply cost structure or scale issues preventing conversion to profitability. Ongoing losses depress ROE and reduce retained capital for reinvestment, challenging long-term shareholder value creation without structural improvement.
Sales execution and customer acquisition issues
Management acknowledges inconsistent sales execution and slower new-customer acquisition, which are structural risks for a SaaS/subscription company. Weaknesses in go-to-market execution can delay revenue realization from bookings, raise CAC, and undermine the benefits of partnerships and product investments over multiple quarters.

Wandisco (CRTA) vs. iShares MSCI United Kingdom ETF (EWC)

Wandisco Business Overview & Revenue Model

Company DescriptionCirata plc, together with its subsidiaries, engages in the development and provision of collaboration software in North America, Europe, China, and internationally. The company's WANdisco Data Activation Platform offers Data Migrator, an automated cloud migration solution that migrates HDFS data and Hive metadata to the cloud; Data Migrator for Azure, a native Azure service that enables users to migrate petabyte-scale Hadoop data and Hive metadata to the Azure cloud; and Edge to Cloud, a tool designed to move IoT and file data across edge systems, data centers, and public clouds to enable organizations to activate their data for AI, machine learning, and advanced analytics on modern cloud data platforms. Its application lifecycle management products include Subversion MultiSite Plus, Git MultiSite, Gerrit MultiSite, and Access Control Plus, as well as offers data migration services. The company was formerly known as WANdisco plc and changed its name to Cirata plc in October 2023. Cirata plc was founded in 2005 and is based in St. Helier, Jersey.
How the Company Makes MoneyWandisco generates revenue primarily through subscription-based licensing of its software products, which provide businesses with the tools necessary for data migration and management. Key revenue streams include annual contracts for its LiveData solutions, professional services for implementation and support, and ongoing maintenance fees. The company has established strategic partnerships with major cloud service providers, enhancing its market reach and driving additional sales through collaborative offerings. Furthermore, Wandisco benefits from a growing demand for cloud migration services and data management solutions, contributing positively to its earnings.

Wandisco Earnings Call Summary

Earnings Call Date:Sep 03, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Apr 08, 2026
Earnings Call Sentiment Neutral
Cirata's earnings call indicates strong revenue and bookings growth, effective cost management, and strategic partnerships, paired with challenges in sales execution and customer acquisition. While there are significant achievements, the need for improved execution in certain areas tempers overall enthusiasm.
Q2-2025 Updates
Positive Updates
Significant Revenue Growth
Revenue for the first half of 2025 rose to $4.8 million, up from $3.4 million a year ago, marking an increase of over 40%.
Strong Bookings Performance
Bookings increased to $3.8 million, a 58% year-on-year rise, with data integration bookings up over 200%.
Cash Overheads Reduction
Cash overheads decreased significantly to $8.5 million from $11.8 million last year, showing improved efficiency.
Enterprise Contracts and Partnerships
Successfully signed 20 contracts, including an enterprise-wide license agreement with a top 20 retailer and a new partnership with Microsoft Azure.
DevOps Divestiture
Completed the divestiture of DevOps assets to BlueOptima, expected to yield up to $3.5 million in cash, allowing focus on data integration.
New Leadership in Sales
Appointment of Dominic Arcari as Chief Revenue Officer to strengthen sales execution.
Negative Updates
Disappointing Q2 Performance
Q2 results were below expectations, failing to demonstrate consistent quarterly progress.
Challenges in New Customer Acquisition
Discontent with the speed of execution in sourcing and acquiring new customers.
Sales and Marketing Execution Issues
Acknowledgement of previous failures to perform sales basics consistently.
Company Guidance
In the recent call, Cirata reported significant progress in the first half of fiscal year 2025, with revenues rising over 40% to $4.8 million from $3.4 million a year ago, and bookings increasing by 58% to $3.8 million. The company achieved a notable reduction in cash overheads, from $11.8 million to $8.5 million, contributing to the halving of its adjusted EBITDA loss from $8.6 million to $4 million. Cirata ended June with a cash plus receivables position of $7.4 million. The data integration segment, a core focus for Cirata, showed robust growth, with bookings in this area soaring over 200% year-on-year to $3.1 million. Despite a disappointing Q2, the first half data integration bookings were up significantly, and the company successfully signed 20 contracts, including an enterprise-wide license with a top retailer. Strategic moves, such as divesting DevOps assets to BlueOptima, resulted in up to $3.5 million in cash and allowed Cirata to concentrate on its data integration business. Additionally, the appointment of Dominic Arcari as Chief Revenue Officer is expected to enhance sales execution. The outlook remains positive, with expectations of continued triple-digit growth in data integration and no further working capital fundraise needed in FY '25.

Wandisco Financial Statement Overview

Summary
Cirata faces significant financial challenges with declining revenues, substantial operating losses, and negative cash flows. Despite a conservative capital structure, the inability to generate positive cash flow and profits undermines financial stability.
Income Statement
45
Neutral
The company has shown a declining revenue trend with a negative revenue growth rate from 2020 to 2024. The gross profit margin is relatively high, indicating efficient production, but the net profit margin is severely negative due to substantial losses, highlighting ongoing operational challenges. EBIT and EBITDA margins are also deeply negative, which suggests significant inefficiencies and cost control issues.
Balance Sheet
55
Neutral
The company has a relatively high equity ratio, indicating a conservative capital structure with low leverage. However, the return on equity is negative due to consistent net losses, which raises concerns about the company's ability to generate shareholder value. Despite low debt levels, the persistent losses are a financial strain.
Cash Flow
40
Negative
The company has experienced negative free cash flow for several years, indicating that it is not generating sufficient cash to cover operational and capital expenditure. The operating cash flow to net income ratio is poor, suggesting cash flow issues. There is also a significant reliance on financing activities, which could lead to sustainability issues in the long term.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue7.46M7.68M6.70M9.69M7.31M10.53M
Gross Profit6.75M7.14M6.06M8.99M6.65M9.47M
EBITDA-9.28M-14.39M-36.69M-39.13M-32.47M-33.27M
Net Income-17.52M-13.51M-36.48M-29.61M-37.59M-34.33M
Balance Sheet
Total Assets10.36M14.92M23.11M26.54M42.19M41.32M
Cash, Cash Equivalents and Short-Term Investments6.08M9.73M18.25M19.11M27.76M21.04M
Total Debt749.00K889.00K795.00K539.00K1.82M2.89M
Total Liabilities4.94M5.35M6.50M8.64M7.76M12.12M
Stockholders Equity5.42M9.57M16.61M16.56M34.42M29.19M
Cash Flow
Free Cash Flow-8.98M-14.88M-30.67M-27.70M-34.00M-24.23M
Operating Cash Flow-8.86M-14.77M-30.60M-27.50M-28.23M-18.71M
Investing Cash Flow-121.76K-107.00K-43.00K-158.00K-5.76M-5.51M
Financing Cash Flow6.13M6.44M29.10M19.48M40.79M21.82M

Wandisco Technical Analysis

Technical Analysis Sentiment
Negative
Last Price21.00
Price Trends
50DMA
20.02
Negative
100DMA
19.64
Negative
200DMA
21.87
Negative
Market Momentum
MACD
-0.48
Positive
RSI
37.90
Neutral
STOCH
5.91
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CRTA, the sentiment is Negative. The current price of 21 is below the 20-day moving average (MA) of 21.14, above the 50-day MA of 20.02, and below the 200-day MA of 21.87, indicating a bearish trend. The MACD of -0.48 indicates Positive momentum. The RSI at 37.90 is Neutral, neither overbought nor oversold. The STOCH value of 5.91 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:CRTA.

Wandisco Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
£200.75M19.3411.31%1.68%6.27%0.83%
70
Outperform
£96.55M13.315.30%-3.95%16.87%
68
Neutral
£121.09M32.8912.39%0.79%12.10%27.35%
68
Neutral
£215.66M51.029.59%0.80%22.80%-32.13%
68
Neutral
£199.32M-996.43-2.20%31.86%-115.22%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
54
Neutral
£22.74M-1.61-268.88%1.65%29.02%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:CRTA
Wandisco
18.50
-1.42
-7.13%
GB:ACSO
accesso Technology
270.00
-230.00
-46.00%
GB:DOTD
Dotdigital
66.60
-16.86
-20.20%
GB:ELCO
Eleco
144.00
1.43
1.00%
GB:NET
Netcall
125.00
11.97
10.59%
GB:AOM
ActiveOps plc
277.00
173.50
167.63%

Wandisco Corporate Events

Executive/Board Changes
Cirata Grants Performance-Linked Share Options to CTO and CRO
Positive
Feb 4, 2026

Cirata plc has granted new equity-based awards under its Share Options Plan to Chief Technical Officer Paul Scott Murphy and Chief Revenue Officer Dominic Arcari, reflecting the board’s use of long-term incentives to align senior leadership with shareholder interests. Murphy received options over 600,000 ordinary shares, split between time-based options priced at 20.6 pence vesting quarterly to February 2029 and performance-based options at a 10 pence strike that vest in December 2027 only if the share price reaches at least 75 pence, taking his total option holding to 1.06% of the company’s share capital alongside a small direct shareholding. Arcari was awarded 300,000 performance-based options at a 10 pence strike subject to the same 75 pence share price hurdle by December 2027, lifting his option holding to 0.51% of outstanding shares and reinforcing performance-linked remuneration as Cirata seeks to motivate and retain key executives while tying their rewards to long-term share price appreciation.

The most recent analyst rating on (GB:CRTA) stock is a Sell with a £20.50 price target. To see the full list of analyst forecasts on Wandisco stock, see the GB:CRTA Stock Forecast page.

Business Operations and StrategyFinancial DisclosuresM&A TransactionsProduct-Related Announcements
Cirata posts record Data Integration bookings as it refocuses on core data platforms
Positive
Jan 14, 2026

Cirata reported a record finish to FY25, with Data Integration bookings surging 181% year-on-year to $13.2m and Q4 DI bookings hitting an all-time quarterly high of $9.8m, underpinned by the largest direct contract ($3.1m with a leading US insurer) and the largest OEM contract ($6.7m via IBM) in the company’s history. Following the strategic divestment of its renewal-heavy DevOps business for a total $3.4m, the group has refocused entirely on higher-growth Data Integration and Orchestration products, launched its Cirata Symphony platform, sharply reduced annualised cash overheads to about a third of their FY21 peak and cut annual cash burn to $5.7m, positioning management to target cash-flow breakeven in FY26 and signalling a leaner, expansion-led growth strategy geared toward existing blue-chip clients and new enterprise wins.

The most recent analyst rating on (GB:CRTA) stock is a Hold with a £19.50 price target. To see the full list of analyst forecasts on Wandisco stock, see the GB:CRTA Stock Forecast page.

Business Operations and StrategyM&A Transactions
Cirata Receives Final US$900,000 from BlueOptima for DevOps Asset Sale
Positive
Dec 19, 2025

Cirata plc has received the final consideration payment of US$900,000 from BlueOptima following the completion of the divestment of its DevOps assets, confirming that no further sums are due under the transaction agreed earlier in 2025. The receipt of this final payment closes out the DevOps disposal process, providing full clarity on proceeds from the sale and allowing Cirata to move forward with its refocused operations without any remaining financial contingencies related to the transaction.

The most recent analyst rating on (GB:CRTA) stock is a Hold with a £19.50 price target. To see the full list of analyst forecasts on Wandisco stock, see the GB:CRTA Stock Forecast page.

Business Operations and StrategyLegal ProceedingsRegulatory Filings and Compliance
Cirata Cleared by FCA, Embarks on New Growth Chapter
Positive
Nov 27, 2025

Cirata plc, a company in the UK tech sector, has announced that the Financial Conduct Authority (FCA) has closed its investigation into the company without taking any action. The investigation, which began in April 2023, focused on whether Cirata had mis-stated its financial position in regulatory announcements between May 2021 and March 2023. CEO Stephen Kelly highlighted the efforts of the new management team in restructuring the company and launching the Cirata Symphony Data Orchestration Platform, marking a new chapter for the company.

The most recent analyst rating on (GB:CRTA) stock is a Hold with a £19.50 price target. To see the full list of analyst forecasts on Wandisco stock, see the GB:CRTA Stock Forecast page.

Business Operations and Strategy
Cirata Secures Landmark $6.7M Contract with IBM
Positive
Nov 17, 2025

Cirata plc has secured a significant $6.7 million, three-year contract with IBM to provide data integration software for a financial services client. This contract, the largest in Cirata’s history with IBM, is expected to enhance Cirata’s standing in the financial services market and strengthen its strategic partnership with IBM.

The most recent analyst rating on (GB:CRTA) stock is a Hold with a £19.50 price target. To see the full list of analyst forecasts on Wandisco stock, see the GB:CRTA Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 07, 2025